USAntibiotics Plans Bristol, Tennessee, Research-Manufacturing Campus
09/03/2021
Located at 201 Industrial Drive, the 360,000-square-foot facility was acquired by Jackson Healthcare with plans to re-open the former pharmaceutical manufacturing site.
“USAntibiotics is focused on what it does best, producing life-saving antibiotics and making them accessible to all Americans. We are proud to have our operations in the state of Tennessee and of the role we play in manufacturing high-quality, made in America products that support health and wellness and that reduce our dependence on vital medications produced outside our country” said Rick Jackson, CEO, Jackson Healthcare, parent company of USAntibiotics.
“We are proud to support USAntibiotics in its critical mission to manufacture two of the most commonly prescribed antibiotics in the country. Tennessee offers companies around the globe a business-friendly climate and skilled workforce, and we are pleased to welcome USAntibiotics to the state as it sets up new operations in Sullivan County,” noted TNECD Commissioner Bob Rolfe.
The Department of Homeland Security has identified USAntibiotics as critical infrastructure since it is the only manufacturing facility in the United States that is authorized to produce Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil and Augmentin. These are two of the most widely prescribed antibiotics in the U.S. and this investment will greatly bolster the U.S.’ capabilities to produce its own essential antibiotics.
“We are known for being a leader in a lot of things here, the Birthplace of Country Music, the first public utility to win a Malcolm Baldrige Award with BTES, the World’s Fastest Half Mile at Bristol Motor Speedway, so why not Bristol, Tennessee as the reshoring center of our nation’s antibiotic production. It’s this culture, particularly in our workforce, that was the real difference maker in attracting US Antibiotics. This is a great fit of a company and a community and I’m excited to see all of the great things the future has in store for US Antibiotics, Bristol and Northeast Tennessee,” said David Wagner, Bristol Industrial Development Board chairman, vice-chairman of NETWORKS Sullivan County Partnership.
Project Announcements
Create Energy Expands-Plans Sumner County-Robertson County, Tennessee, Operations
03/20/2026
United Kingdom-Based Dechra Plans Boston, Massachusetts, Headquarters Operations
03/20/2026
France-Based Bel Group Expands Brookings, South Dakota, Production Operations
03/20/2026
Menco Plans Menominee County, Michigan, Operations
03/20/2026
Southern Energy Renewables Plans St. Charles Parish, Louisiana, Methanol-Aviation Fuel Operations
03/20/2026
FCH Plans West Chester, Ohio, Production Operations
03/20/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025
-
Last Word: Don’t Lose by Winning
Q1 2026